Taro Pharmaceutical
TARO
$38.03
Share price
-0.39%
Change (1 day)
4.77%
Change (1 year)
Categories
Taro Pharmaceutical (TARO) - Cash on Hand
Cash on Hand as of September 2022 : $0.83 B
According to Taro Pharmaceutical's latest financial reports the company has $0.83 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Taro Pharmaceutical - Cash on Hand chart (from 2001 to 2022)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-03-31 | $0.82 B | -19.82% |
| 2021-03-31 | $1.02 B | -7.67% |
| 2020-03-31 | $1.10 B | 5.66% |
| 2019-03-31 | $1.04 B | -26.24% |
| 2018-03-31 | $1.42 B | 2.59% |
| 2017-03-31 | $1.38 B | 12.87% |
| 2016-03-31 | $1.22 B | 33.55% |
| 2015-03-31 | $0.91 B | 45.53% |
| 2014-03-31 | $0.63 B | 14.3% |
| 2013-03-31 | $0.55 B | |
| 2011-12-31 | $0.24 B | 173.21% |
| 2010-12-31 | $88.83 M | -22.26% |
| 2009-12-31 | $0.11 B | 44.98% |
| 2008-12-31 | $78.82 M | 74.45% |
| 2007-12-31 | $45.18 M | 178.01% |
| 2006-12-31 | $16.25 M | -77.68% |
| 2005-12-31 | $72.82 M | -26.16% |
| 2004-12-31 | $98.63 M | -38.02% |
| 2003-12-31 | $0.15 B | 21.73% |
| 2002-12-31 | $0.13 B | -14.65% |
| 2001-12-31 | $0.15 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $23.51 B | 2,701.58% | 🇺🇸 USA |
 Novartis NVS | $12.26 B | 1,360.41% | 🇨🇭 Switzerland |
 Pfizer PFE | $22.73 B | 2,607.83% | 🇺🇸 USA |
 Merck MRK | $13.19 B | 1,471.43% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $8.64 B | 929.21% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $2.80 B | 233.65% | 🇮🇱 Israel |